Bio-Rad Laboratories Class A
273 hedge funds and large institutions have $3.8B invested in Bio-Rad Laboratories Class A in 2017 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 105 increasing their positions, 84 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 260 → 273 (+13)
2.93% less ownership
Funds ownership: 80.77% → 77.84% (-2.9%)
99% less call options, than puts
Call options by funds: $638K | Put options by funds: $99.6M
Holders
273
Holding in Top 10
10
Calls
$638K
Puts
$99.6M
Top Buyers
| 1 | +$342M | |
| 2 | +$71.7M | |
| 3 | +$59.8M | |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$24.2M |
| 5 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
+$20M |
Top Sellers
| 1 | -$159M | |
| 2 | -$48.8M | |
| 3 | -$42.4M | |
| 4 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$40.9M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$31.4M |